Author Archives: admin


Stem Cell Clinic > Articles by: admin

Cancer Therapy Market 2020 | Remarkable Growth Factors with Industry Size & Share, New Innovations of Leading Players & Forecast till 2024 -…

By Gene Therapy Clinics

Pfizer Inc.

Cancer Therapy Market Report Highlights:

Scope of the Report:

As per the , cancer therapies are drugs that block the growth and proliferation of cancer, by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. These therapies include surgery, radiation therapy, chemotherapy, immunotherapy, etc.

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999546

Key Market Trends:

The Target Therapy Segment is Expected to show the Fastest Growth in the Forecast Period

The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells.

The breast cancer segment is belived to account for the largest market size over the forecast period. This is majorly attrobuted to the higher and continuously increaisng prevalence of breast cancer acoss the world. As per estimates provided by the Breast Cancer Organization in 2018, it is estimated that over 2,66,120 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 63,960 new cases of non-invasive (in situ) breast cancer.

North America Currently Dominates the Cancer Therapy Market and is Expected to Continue in the Forecast Period

North America currently dominates the market for cancer therapy and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of cancer therapy. The United States holds majority of the market in the North American region, due to the rising prevalence of cancer in the country. According to the National Cancer Institute (NCI), in 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing in the United States.

The Report Covers:

Purchase this Report (Price 4500 USD for single user license) https://www.industryresearch.co/purchase/13999546

Detailed TOC of Cancer Therapy Market Report 2019-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Increasing Patient Assistance Programs (PAPs) 4.2.2 Growing Government Initiatives for Cancer Awareness 4.2.3 Rising Prevalence of Cancer Worldwide 4.2.4 Strong R&D Initiatives from Key Players 4.3 Market Restraints 4.3.1 Fluctuation in Reimbursement Policies 4.3.2 High Cost of Cancer Therapies 4.4 Porters Five Force Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Treatment Type 5.1.1 Chemotherapy 5.1.2 Targeted Therapy 5.1.3 Immunotherapy 5.1.4 Hormonal Therapy 5.1.5 Other Treatment Types 5.2 By Cancer Type 5.2.1 Blood Cancer 5.2.2 Breast Cancer 5.2.3 Prostate Cancer 5.2.4 Gastrointestinal Cancer 5.2.5 Gynecologic Cancer 5.2.6 Respiratory/Lung Cancer 5.2.7 Other Cancer Types 5.3 By End User 5.3.1 Hospitals 5.3.2 Spcialty Clinics 5.3.3 Cancer and Radiation Therapy Centers 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 South Korea 5.4.3.5 Australia 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle East & Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle East & Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Amgen Inc. 6.1.2 AstraZeneca PLC 6.1.3 Bayer AG 6.1.4 Johnson and Johnson 6.1.5 Merck & Co. Inc. 6.1.6 F. Hoffmann-La Roche AG 6.1.7 Eli Lilly and Company 6.1.8 Novartis AG 6.1.9 Pfizer Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Octreotide Acetate Market Future Growth Rate 2020 | Comprehensive Overview of Global Key Players with COVID-19 Impact, Industry Size and Share by Trends, Development Plans till 2026

Cultivator Market Size and Share by Top Players 2020 | COVID-19 Impact on Global Industry, Business Opportunities, Growth Trends and Demand till 2026

Soft Optical Glass Market Size and Share by Top Players 2020 | COVID-19 Impact on Global Industry, Business Opportunities, Growth Trends and Demand till 2026

Centrifugal Dental Vacuum Pumps Market Size Outlook 2020 to 2025: Market Trends, Segmentation, Growth Rate and Competitive Landscape with COVID-19 Outbreak

Specialty Ceramics Market Size by Top Key Players 2020 Global Growth Rate by Share, Industry Segment, Future Prospect, Key Finding and Market Dynamics Forecast to 2026

Originally posted here:
Cancer Therapy Market 2020 | Remarkable Growth Factors with Industry Size & Share, New Innovations of Leading Players & Forecast till 2024 -...

Global Cryopreservation Equipment Market Research Report 2020 by Key Players, Types, Applications, Market Size, Countries and Forecast to 2026 -…

By Stell Cell Research

Cryopreservation Equipment Market is systematic exploration that delivers key statistics on the market status of the development trends, competitive landscape analysis, and key regions development status. The report has included strong players and analyses their limitations and strong points of the well-known players through SWOT analysis. This Report covers growing trends that are linked with major opportunities for the expansion of the Cryopreservation Equipment industry.

Get Free Sample Report(including full TOC, Tables and Figures): @ https://www.globalmarketers.biz/report/chemicals-and-materials/global-cryopreservation-equipment-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155410#request_sample

Brooks Automation, Inc. Custom Biogenic Systems BioLifeSolutions, Inc. Merck KGaA Thermo Fisher Scientific, Inc. PHC Corporation VWR International, LLC Beckman Coulter, Inc. Hamilton Company Bluechiip Ltd.

The Geographical Analysis Covers the Following Regions

The recent outbreak of the COVID-19 (Corona Virus Disease) Provide extra commentary on the newest scenario, an economic slowdown on the overall industry. In addition to this, the report also includes the development of the Cryopreservation Equipment market in the major regions across the world.

Note: Upto 30% Discount: Get this reports in Discounted Price

Ask For Discount: https://www.globalmarketers.biz/discount_inquiry/discount/155410

Global Cryopreservation Equipment Market Segmentation: By Types

Freezers Accessories Liquid Nitrogen

Global Cryopreservation Equipment Market Segmentation: By Applications

Stem Cell Banks Biotechnology & Pharmaceutical Organizations Stem Cell Research Laboratories Others

Do you want any other requirement or customize the report, Do Inquiry Here: https://www.globalmarketers.biz/report/chemicals-and-materials/global-cryopreservation-equipment-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155410#inquiry_before_buying

This research report represents a 360-degree overview of the competitive landscape of the Cryopreservation Equipment Market. Furthermore, it offers enormous statistics relating to current trends, technological advancements, tools, and methodologies.

Global Cryopreservation Equipment Market Research Report 2020

Chapter 1 About the Cryopreservation Equipment Industry

Chapter 2 World Market Competition Landscape

Chapter 3 World Cryopreservation Equipment Market share

Chapter 4 Supply Chain Analysis

Chapter 5 Company Profiles

Chapter 6 Globalization & Trade

Chapter 7 Distributors and Customers

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries

Chapter 9 World Cryopreservation Equipment Market Forecast through 2026

Chapter 10 Key success factors and Market Overview

It concludes by throwing light on the recent developments that took place in the Cryopreservation Equipment market and their influence on the future growth of this market.

Table of Content & Report Detail @ https://www.globalmarketers.biz/report/chemicals-and-materials/global-cryopreservation-equipment-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/155410#table_of_contents

More here:
Global Cryopreservation Equipment Market Research Report 2020 by Key Players, Types, Applications, Market Size, Countries and Forecast to 2026 -...

Stem Cell Banking Market Trends and Growth, Outlook, Research, Trends and Forecast to 2028 – Cole of Duty

By Stem Cell Medicine

Global Stem Cell Banking Market: Overview

The demand within the global stem cell banking market is growing on account of advancements in the field of regenerative medicine. The medical fraternity has become extremely focused towards the development of artificial tissues that can infuse with the human body. Furthermore, medical analysis and testing has gathered momentum across biological laboratories and research institutes. Henceforth, it is integral to develop stem cell samples and repositories that hold relevance in modern-day research. The need for regenerative medicine emerges from the growing incidence of internal tissue rupture. Certain types of tissues do not recover for several years, and may even be damaged permanently. Therefore, the need for stem cell banking is expected to grow at a significant pace.

Download Brochure of This Market Report at https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6111

In a custom report, TMR Research digs into the factors that have aided the growth of the global stem cell banking market. The global stem cell banking market can be segmented on the basis of bank size, application, and region. The commendable developments that have incepted across the US healthcare industry has given a thrust to the growth of the North America stem cell banking market.

Global Stem Cell Banking Market: Notable Developments

The need for improved regenerative medication and anatomy has played an integral role in driving fresh developments within the stem cell banking market.

Gallant has emerged as a notable market entity that has remained as the torchbearer of innovation within the global stem cell banking market. The company has recently launched stem cell banking for dogs, and has attracted the attention of the masses. As people become increasingly concerned about their pets, the new move by Gallant shall help the company in earning the trust of the consumers. Moreover, it can move several notches higher on the innovation index.

Cells4Life has also remained at the forefront of developments within the global stem cell banking market. After suffering backlash for its error in cord blood stem cell promotion, the company is expected to use effective public relation strategies to regain its value in the market.

Global Stem Cell Banking Market: Growth Drivers

Development of improved facilities for storage of stem cells has played an integral role in driving market demand. Furthermore, the unprecedented demand for improved analysis of regenerative medications has also created new opportunities within the global stem cell banking market. Medical research has attracted investments from global investors and stakeholders. The tremendous level of resilience shown by biological researchers to develop stem cell samples has aided market growth. Henceforth, the total volume of revenues within the global stem cell banking market is slated to multiply.

Commercialization of stem cell banks has emerged as matter of concern for the healthcare industry. However, this trend has also helped in easy storage and procurement of cells stored during the yester years of children. Presence of sound procedures to register at stem cell banks, and the safety offered by these entities, has generated fresh demand within the global market. New regional territories are opening to the idea of stem cell banking. Several factors are responsible for the growth of this trend. Primarily, improvements in stem cell banking can have favourable impact on the growth of the healthcare industry. Moreover, the opportunities for revenue generation associated with the development of functional stem cell banks has aided regional market growth.

The global stem cell banking market is segmented on the basis of:

Source

Request For TOC On this Market Report at https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6111

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read more from the original source:
Stem Cell Banking Market Trends and Growth, Outlook, Research, Trends and Forecast to 2028 - Cole of Duty

Artificial Blood Market Excellent Growth 2024 | also understand the impact of COVID-19 situation across the globe – 3rd Watch News

By Stem Cell Doctors

Global Artificial Blood Market is estimated to reach $10.73 billion by 2025; growing at a CAGR of 20.3% from 2017 to 2025. Artificial blood, also known as synthetic blood substitute or blood surrogate is a substance used as a replacement to biological blood. It is intended to offer an alternate to blood transfusion, transfer of blood or blood-based products from one to another individual. By use of artificial blood, it can be possible for doctors and surgeons to sidestep the risk of disease transmission and immune suppression and address the chronic blood donor shortage.

Main aim of artificial blood use is transportation of oxygen and carbon dioxide across the body. In every year, thousands of people die due to blood loss during traumatic injuries & diseases. The increasing need of an alternate to overcome blood supply shortage & increased awareness and incidence of transfusion transmitted diseases led to the discovery of artificial blood substitutes.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10325348

Key factors driving the growth of the global artificial blood market include need for an alternate to overcome blood supply shortage, lack of blood donors, growing demand for blood transfusion in cases like blood loss during surgeries, anemia, and trauma, and anemia, growing occurrence of disease looking for medical surgeries, and military wars & trauma cases. On the flip side, uncertainty & lower shelf life of artificial blood products and strict regulatory approval process may hamper the growth of the artificial blood market. Moreover, arrival of stem cell therapy would create new opportunities for players in this market.

The artificial blood market has been categorized on the basis of source, type, product, and geography. Source includes human blood, synthetic blood, and animal blood. By type, market is categorized into hemoglobin-based oxygen carriers (HBOCs), and perflurocarbon emulsions (PFCEs). Product includes hemospan, hemopure, polyheme, hemolink, hemotech, oxycyte, hemoassist, VIDAPHOR, PHER-O2, DDFPe, and sanguinate.

Global artificial blood market, on the basis of geography is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated into U.S., Canada, and Mexico whereas Europe segment consist of UK, Russia, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific while RoW is bifurcated into South America, Middle East, and Africa.

The key players operating in the market are Dextro-Sang Corporation, BioPure Corporation, Sangart, Inc., Northfield Laboratories, Baxter International, Dentritech, Inc., FluorO2 Therapeutics, Inc., Nuvox Pharma Llc, Alpha Therapeutic Corporation, and HemoBioTech, Inc., among others.

Request For Full Report:https://www.kennethresearch.com/sample-request-10325348

The key takeaways from the report The report will provide detailed analysis of Global Artificial Blood Market with respect to major segments such as source, type, and product The report will include the qualitative and quantitative analysis with market estimation over 2016 2025 and compound annual growth rate (CAGR) between 2017 and 2025

Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report An exhaustive regional analysis of Global Artificial Blood Market has been included in the report

Profile of the key players in the Global Artificial Blood Market will be provided, which include key financials, product & Synthetic Platelets, new developments and business strategies

Scope of the Global Artificial Blood Market

Source Segments

Human Blood Synthetic Blood Animal Blood Type Segments

Hemoglobin-Based Oxygen Carriers (HBOCs) Perflurocarbon Emulsions (PFCEs) Product Segments

HemoSpan Hemopure PolyHeme HemoLink HemoTech Oxycyte HemoAssist VIDAPHOR PHER-O2 DDFPe Sanguinate Geographical Segments

North America U.S. Canada Mexico Europe UK Russia Germany France Italy Rest of Europe Asia-Pacific India China Japan South Korea Rest of Asia-Pacific RoW South America Middle East Africa

<<<<<>>>>> Low NOx Burner Market Machine Tool Market U.S. Live Webinar Software Market Queue Management System Market Real Estate Crowdfunding Market Multi-Phase Production Pumps Market

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : [emailprotected]

Phone: +1 313 462 0609

Go here to read the rest:
Artificial Blood Market Excellent Growth 2024 | also understand the impact of COVID-19 situation across the globe - 3rd Watch News

Adipose Derived Stem Cell Therapy Market : Latest Innovations, Drivers and Industry Key Events 2019-2025 Bulletin Line – Bulletin Line

By Stell Cell Research

Study of the Global Adipose Derived Stem Cell Therapy Market

The recently published market study on the global Adipose Derived Stem Cell Therapy market provides a detailed analysis of the various factors that are expected to impact the growth of the Adipose Derived Stem Cell Therapy market in the upcoming years. As per the report, the Adipose Derived Stem Cell Therapy market is set to grow at a CAGR of ~XX% during the assessment period (2019-2029) and exceed the value of ~US$XX% by the end of 2029.

The report offers a granular assessment of the various segments and sub-segments of the Adipose Derived Stem Cell Therapy market and the data is depicted in the form of tables, figures, and graphs. Readers can leverage the data enclosed in the report to formulate effective business strategies to enhance their position in the Adipose Derived Stem Cell Therapy market landscape.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2694812&source=atm

Essential Findings of the Report

Bifurcation of the Global Adipose Derived Stem Cell Therapy Market

segment by Type, the product can be split into Autologous Stem Cells Allogeneic Stem Cells Market segment by Application, split into Therapeutic Application Research Application

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Adipose Derived Stem Cell Therapy status, future forecast, growth opportunity, key market and key players. To present the Adipose Derived Stem Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adipose Derived Stem Cell Therapy are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2694812&source=atm

The report aims to resolve the following doubts related to the Adipose Derived Stem Cell Therapy market:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2694812&licType=S&source=atm

Go here to see the original:
Adipose Derived Stem Cell Therapy Market : Latest Innovations, Drivers and Industry Key Events 2019-2025 Bulletin Line - Bulletin Line

Bone Marrow Transplant Market Is Anticipated To Reach Significant Valuation by 2021 by Expanding at a CAGR of 4.2% (Impact Analysis of COVID-19) – 3rd…

By Stell Cell Research

Global Bone Marrow Transplantation Market Overview

Bone marrow is the spongy, greasy tissue present in the bone cavities. The bone marrow transplant procedures are being carried out for various medical conditions. Bone marrow transplant also is known as hematopoietic stem cell helps in curing the critical medical conditions surfaced due to damaged bone marrow cells. The technique replaces the old damaged tissues with new ones and helps in curing many diseases.

The CAGR value Could change due to COVID-19 Pandemic on Global Industry

More than 75,000 bone marrow transplants were executed around the globe during the year 2015 which are further anticipated to reach a significant valuation by 2021 by expanding at a compound annual growth rate of 4.2% over the forecast period.

Request To Fill The form for Sample Copy of This Report:https://www.kennethresearch.com/sample-request-10075217

Market Size and Forecast

Globally, Europe has a fairly large market share and it is expected to remain at its top position when compared to other geographies; accounting for 60% of global revenue share and anticipated to touch USD 6.05 Billion in the year 2021. At present, North America is the second biggest market after Europe. Factors like increasing cases of chronic diseases like blood cancer in sync with an up-surged aged population would help the bone marrow industry to flourish in the region.

Asia pacific bone marrow transplantation market might not be as big as those in Europe and North America but would become an attractive market for medical procedures for medical tourists (due to low-cost procedures).

Key Players of Global Market:

Sanofi-Aventis LLC., PromoCell GmbH, STEMCELL Technologies, Lonza Group Ltd., ReachBio LLC., AllCells LLC., ATCC Inc., Lifeline Cell Technology, Conversant Bio, Hemacare Corporation, and Others.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Request To Fill The form for Sample Copy of This Report:https://www.kennethresearch.com/sample-request-10075217

Growth Drivers and challenges

Increasing the prevalence of anemia and cancers across the globe is the major growth driver for the global bone marrow transplantation market. In addition to that, improvement in technology, development in healthcare infrastructure, increased penetration of medical insurances and expanded personal disposable income around the world are expected to drive global bone marrow transplantation.

High costs involved in the treatment and lack of or less number of bone marrow donors are the major challenges for the global bone marrow transplantation market.

Market Segmentation

Based on transplantation type, the global bone marrow transplantation market is the segmented basis:

Allogeneic Bone marrow Transplantation Autologous Bone Marrow Transplantation

Disease Indication

Based on the disease indication, the global bone marrow transplantation market is divided into the following:

Lymphoma Leukemia Myeloma Myelodysplasia Aplastic Anemia Sickle-cell Anemia Solid tumors Thalassemia Myeloproliferative Neoplasms Others

Request To Fill The form for Sample Copy of This Report:https://www.kennethresearch.com/sample-request-10075217

End-User

Based on the end-user type, the global bone marrow transplantation market can be segmented into:

Multispecialty Clinics Hospitals Ambulatory Surgical Centers By Region

On the basis of region the global bone marrow transplantation market is segmented into:

North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis The Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Dont miss the business opportunity of the Global Market. Consult our analyst and gain crucial insights and facilitate your business growth.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations, and organizations with the aim of helping them to take prominent decisions. Our research library comprises more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both the macro level as well as micro-level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis of various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keeps a track of the international and domestic market for any economic changes impacting the products demand, growth, and opportunities for new and existing players.

Updated Research Report Available @Kenneth Research with impact analysis of COVID-19

Short Fiber Reinforced Thermoplastic Composite Market Short Fiber Thermoplastic Composites Market Silane Market Porcine Gelatin Market Polyvinyl Chloride (PVC) Market Polyurethane Market

More here:
Bone Marrow Transplant Market Is Anticipated To Reach Significant Valuation by 2021 by Expanding at a CAGR of 4.2% (Impact Analysis of COVID-19) - 3rd...

Cancer: ‘Off-the-shelf’ stem cell treatment enters …

By Stem Cell Treatment

In a first-of-its-kind trial in the United States, researchers are testing a stem cell-derived natural killer cell immunotherapy in people with incurable cancer.

Cancer follows heart disease as the second biggest killer worldwide. In the United States, an estimated 606,880 people will die due to cancer in 2019.

With the advent of immunotherapy, researchers hoped to boost a persons immune system to fight and destroy tumors effectively. Although this type of therapy has completely changed the treatment landscape for cancers such as melanoma, there remain a significant number of people whose tumors can evade their immune system.

Joining the likes of adoptive cell transfer and checkpoint inhibitors on the list of immunotherapies are natural killer (NK) cells. These specialized white blood cells come equipped with a potent armory of tools to make short work of cancer cells.

Now, researchers at the University of California (UC) San Diego School of Medicine are running a clinical trial with industrial collaborator Fate Therapeutics to investigate NK cells both alone and in combination with checkpoint inhibitors in people with advanced solid tumors.

One particular factor sets this study apart from others using NK cells for similar purposes.

This off-the-shelf NK immunotherapy trial is the first in the U.S. to use cells that the researchers have derived from induced pluripotent stem (iPS) cells.

Scientists first developed iPS cells in 2006 by switching on four dormant genes in skin cells. Doing this completely changed the characteristics of these cells and reverted them to an embryonic-like state.

Now widely hailed as an alternative to embryonic stem cells, iPS cells can, like their embryonic counterparts, develop into any type of cell.

For scientists who work on cell therapies, this provides a solution to a major stumbling block in advancing their technologies to clinical application.

Many therapies make use of a patients own cells or cells from a donor. While this type of personalized treatment is the mainstay of current cell therapy applications, it is costly and time-consuming.

The use of iPS cells, on the other hand, allows researchers to produce a never-ending stream of cells. All that they need is a robust method to turn iPS cells into the particular cell type that they require.

A single iPS cell can thus become an off-the-shelf source of cells for therapy, which it is easy to produce time and time again.

Back in 2013, Dr. Dan Kaufman professor of medicine in the Division of Regenerative Medicine and director of cell therapy at UC San Diego School of Medicine and his team developed a method of expanding large numbers of NK cells from human iPS cells for cancer therapy.

They published the method in the journal Stem Cells Translational Medicine.

After extensive preclinical testing, the Food and Drug Administration (FDA) gave Dr. Kaufman and Fate Therapeutics the go-ahead last November to set up a phase I clinical trial to test their iPS-derived NK immunotherapy in people with advanced solid tumors.

The phase I trial started in February and will include up to 64 people with advanced, untreatable cancer. The main aim of the trial is to assess the safety of the treatment. The other objectives are to determine the extent to which the tumors respond to NK cell therapy and to find out how long the cells stay in the participants bodies.

The team will administer the cells once per week for 3 weeks, either on their own or in combination with one of three checkpoint inhibitors, namely nivolumab, pembrolizumab, or atezolizumab.

The study is an open-label trial, which means that all of the study participants will know which treatment they are receiving.

This is a landmark accomplishment for the field of stem cell-based medicine and cancer immunotherapy, explains Dr. Kaufman in a press release. This clinical trial represents the first use of cells produced from human-induced pluripotent stem cells to better treat and fight cancer.

Together with Fate Therapeutics, weve been able to show in preclinical research that this new strategy to produce pluripotent stem cell-derived natural killer cells can effectively kill cancer cells in cell culture and in mouse models, he continues.

The first person to receive treatment as part of the trial was Derek Ruff. After 10 years in remission, Mr. Ruff has stage 4 colon cancer, which is progressing despite aggressive treatment.

Coming to a [National Cancer Institute] cancer center means a lot to me. My options arent otherwise good. Some people may not opt for a clinical trial, but for me, I want a chance at a cure.

Derek Ruff

It will be a while before the results of the trial are available, with expectations being that the study will run into 2022. However, it paves the way not only for a new generation of immunotherapies to treat cancer but also for other iPS-derived cell therapies to follow. Watch this space.

Visit link:
Cancer: 'Off-the-shelf' stem cell treatment enters ...

NK Cell Therapy and Stem Cell Therapy Market 2020-26, Research Report Covers Updated Data Considering Impact of Covid-19 on Share, Size and Future…

By Stell Cell Research

NK Cell Therapy and Stem Cell Therapy Market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NK Cell Therapy and Stem Cell Therapy Market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Report Overview: This report covers an analysis of the global NK Cell Therapy and Stem Cell Therapy Market for the forecast period 2020-2026. It unravels that the market is set to register steady growth rate in the coming years. The valuation of the global market is covered for facilitating a comparative study of the past and future data. It also offers a detailed segmental assessment of the market based on different parameters.

Leading Key Players: Chipscreen Biosciences Innate Pharma SA Osiris Therapeutics Chiesi Pharmaceuticals Molmed JCR Pharmaceutical Altor BioScience Corporation Affimed NV Takeda Pharmaceutical Pharmicell Medi-post NuVasive Anterogen

This analysis includes a detailed share analysis of the key players. It also unveils the growth trajectories of the NK Cell Therapy and Stem Cell Therapy Market participants along with their current statuses and key developments. The growth strategies employed by these players are also assessed in the report and are prognosticated to facilitate study of the competitive landscape of the global Artificial Heart Valve Market.

Get Free Sample [emailprotected] https://www.algororeports.com/sample-request/nk-cell-therapy-and-stem-cell-therapy-market-research-report-trends-one-2940079?utm_source=3wnews&utm_medium=53

Drivers and Restraints: The factors that are supposed to lead the expansion of the global market are highlighted in the assessment. The market factors are assessed and analyzed to understand their impact on the growth curve. Similarly, the factors that are presumed to restrain the growth of the market are also studied in the report.

Regional Analysis: The regions covered for the evaluation of the global NK Cell Therapy and Stem Cell Therapy Market are

North America (Covered in Chapter 6 and 13) United States Canada Mexico Europe (Covered in Chapter 7 and 13) Germany UK France Italy Spain Russia Others Asia-Pacific (Covered in Chapter 8 and 13) China Japan South Korea Australia India Southeast Asia Others Middle East and Africa (Covered in Chapter 9 and 13) Saudi Arabia UAE Egypt Nigeria South Africa Others South America (Covered in Chapter 10 and 13) Brazil Argentina Columbia Chile Others

The analysis of these regional segment is followed by a country-level analysis of each for every region. A comparative study of the segments is offered with the inclusion of valuation for every segment on both country and regional level.

Method of Research: The assessment leverages advanced and robust methodologies to provide fact-based actionable insight into the market. Key market divergences are analyzed in the report for deriving accurate information regarding the growth trajectory of the market. These market divergences identified in the research process are current status of the market, ongoing industry trends, past data, latest developments, etc. Cutting-edge data analytical tools are employed for the filtration, validation, and authentication of data collected from primary and secondary research sources. The inputs are collected from credible sources, including but not limited to, paid database services, interviews with stakeholders across the value chain (MDs, CEOs, VPs,etc.), SEC filings, surveys, and whitepaper references among others. Zero deviation from facts is ensured with the utilization of a multi-layer verification process. It also assures adherence to the highest standards of data mapping and value extrapolation. Top-down and bottom-up approaches are executed to authenticate the accuracy of the quantitative data provided in the report.

CONTENTS

ENQUIREY TO BUY REPORT@ https://www.algororeports.com/enquiry/nk-cell-therapy-and-stem-cell-therapy-market-research-report-trends-one-2940079?utm_source=3wnews&utm_medium=53

About Us:

AlgoroReportsis one of the most significant database of online market researches and intelligence reports and services. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends. AlgoroReports Consists of a highly motivated team of young and experienced individual focused on providing clients expert information they need.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

Website: https://www.algororeports.com/

Ph: +1-352-353-0818 (US)

See the rest here:
NK Cell Therapy and Stem Cell Therapy Market 2020-26, Research Report Covers Updated Data Considering Impact of Covid-19 on Share, Size and Future...

Induced Pluripotent Stem Cell Market 2019 by Rising-Trends, Growth Analysis, Industry Share, Product Types, User-Demand, Business Strategy and…

By Stell Cell Research

The global Induced Pluripotent Stem Cell market is forecasted to reach a market value of ~US$ XX Mn/Bn by the end of 2029 registering a CAGR growth of around XX% during the forecast period (2019-2029). The recent market report provides a detailed analysis of the current structure of the Induced Pluripotent Stem Cell market along with the estimated trajectory of the market over the course of the stipulated timeframe.

The report provides an in-depth assessment of the numerous factors that are anticipated to impact the market dynamics with utmost precision and accuracy. The SWOT and Porters Five Forces Analysis provides a clear picture about the current operations of the various market players operating in the global Induced Pluripotent Stem Cell market.

Request Sample Report @https://www.mrrse.com/sample/16525?source=atm

The Induced Pluripotent Stem Cell market report portrays the market share and the application of each of the sub-segments across various verticals.

The Induced Pluripotent Stem Cell market report explains how the Induced Pluripotent Stem Cell is being deployed in different sector.

Competitive landscape:

The report ponders over the market scenario in various geographies and highlights the major opportunities, trends, and challenges faced by market players in each region. An in-depth country wise analysis of each major region provides readers a deep understanding of the regional aspects of the market including, the market share, pricing analysis, revenue growth, and more.

Market Taxonomy

The global iPS cell market has been segmented into:

Cell Type

Application

End User

Region

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/16525?source=atm

The market report on the Induced Pluripotent Stem Cell market addresses some important questions such as:

Crucial data enclosed in the report:

Buy This Report @ https://www.mrrse.com/checkout/16525?source=atm

Read more:
Induced Pluripotent Stem Cell Market 2019 by Rising-Trends, Growth Analysis, Industry Share, Product Types, User-Demand, Business Strategy and...

Felipe Massa gives rare insight into Michael Schumachers condition and recovery – Mirror Online

By Stem Cell Doctors

Michael Schumacher is one of the greatest racing drivers to have ever lived.

But in 2014 he suffered a devastating skiing accident that has kept him out of the public eye ever since.

With a record breaking seven championship wins to his name, five of them consectively, Schumacher has roared to victory more times than any other driver.

After starting karting as a child, the 51-year-old worked his way up to Formula One, spending most of his career driving for Mercedes.

However, he did switch to Ferrari in 1996, who had last won the championship in 1979, and transformed them into one of the most successful teams in the sport.

Even after he retired in 2006, he couldn't get the sport out of his blood and returned to the track just four years later.

Two years later he announced his career as a racing driver really was over for good and Britain's Lewis Hamilton replaced him at Mercedes.

In an emotional speech announcing his decision, Schumacher said while he still felt "able to compete with the best drivers" he wasn't sure if he had the "motivation and energy which is necessary to go on".

Just over a year after he announced his retirement, on December 29, 2013, while skiing with his then 14-year-old son, Mick, Schumacher suffered a devastating accident.

The father and son was skiing down the Combe de Saulire above Meribel in the French Alps.

It was while they were crossing an unsecured off-piste area that Schumacher, an accomplished skiier, fell and hit his head on a rock.

His life was saved by his ski helmet and the racing legend was airlifted to hospital and underwent two operations to save him.

Schumacher was placed in a medically induced coma and his doctors said his condition was stable.

By June the following year, it was reported that Schumacher had regained consciousness and he was transferred to a hospital for rehab.

He was allowed home in September of that year, where his rehab has continued, but where updates about his condition have been few and far between.

His devoted wife, Corinna, and management team have always insisted his health is a private issue and have remained tight-lipped about what, if any, progress the racing legend has made since his injury.

In a rare update just before the sixth anniversary of Schumacher's devastating accident, Corrina said "big things start with small steps".

Then, in January this year, a neurosurgeon has claimed Schumacher's condition has "deteriorated" since the accident just over six six years ago.

Nicola Acciari said: "We must imagine a person very different from the one we remember on the track, with a very altered and deteriorated organic, muscular and skeletal structure,

"All as a result of the brain trauma he suffered."

Back in May, Schumacher's team-mate at Ferrari, Felipe Massa, gave a rare update into the champion's condition.

He said: "I know how he is, I have information. The main thing about all this is that we know his situation is not easy. He is in a difficult phase but we need to respect him and the family."

There finally seemed to be a glimmer of hope when reports last month claimed the F1 ace was to undergo stem cell surgery within days.

It gave hope to Schumacher's fans around the world but just days later the claims seemed to be false.

While his family maintained their silence they are thought to have not even considered the procedure during the coronavirus pandemic.

However, six years after his accident, the racing great is believed to have been left with devastating health complications because he has been confined to his bed for so long.

He is reported to now be suffering from muscle atrophy, which has caused his muscles to waste away and osteoporosis, which weakens bones.

It had been hoped the stem cell surgery would regenerate Schumacher's nervous system and would be carried out by French cardiologist Dr Philippe Menasche.

The doctor has previously managed to graft healthy stems cells onto the heart by replacing damaged ones with a healthy replacement.

While the surgery is deemed to be safe there is currently no evidence as to what impact it would have on the brain.

Read more from the original source:
Felipe Massa gives rare insight into Michael Schumachers condition and recovery - Mirror Online

→←